Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemal Mehta

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Eye (London, England)|June 7, 2020
Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working GroupWinfried M Amoaku, Faruque Ghanchi, Clare Bailey, et al.
Eye (London, England)|July 24, 2020
Correction: Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working GroupWinfried M Amoaku, Faruque Ghanchi, Clare Bailey, et al.
Journal of Ophthalmology|February 24, 2023
Diabetic Macular Oedema Guidelines: An Australian PerspectiveYew Sen Yuen, Jagjit Singh Gilhotra, Michelle Dalton, et al.
Scientific Reports|June 22, 2026
A combined ex vivo fundus imaging-histology protocol for clinicopathological validation of human donor eyes with limited medical historySarrvesa H Vijay Singh, Waiwai Yeap, Lay Khoon Too, et al.
The British Journal of Ophthalmology|March 13, 2021
Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registryAdrian R Hunt, Vuong Nguyen, Catherine P Creuzot-Garcher, et al.
The British Journal of Ophthalmology|October 8, 2025
Minimum set of outcome measures for non-advanced age-related macular degeneration: a Delphi consensus statement by the TRACER (intermediate age-related macular degeneration) study groupMariano Cozzi, Sandrine Zweifel, Konstantinos Balaskas, et al.
BMJ Open|September 11, 2020
HEROIC: a 5-year observational cohort study aimed at identifying novel factors that drive diabetic kidney disease: rationale and study protocolKieran Mccafferty, Ben Caplin, Sinead Knight, et al.
Medrxiv : the Preprint Server for Health Sciences|August 29, 2022
Risk Factors Associated with Post-Acute Sequelae of SARS-CoV-2 in an EHR Cohort: A National COVID Cohort Collaborative (N3C) Analysis as part of the NIH RECOVER programElaine Hill, Hemal Mehta, Suchetha Sharma, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|March 5, 2026
Faricimab for previously-treated eyes with neovascular age-related macular degeneration with inadequate response - 6-month interim analysis of the FURGGHORN studyLong T Phan, Jennifer Chin, Geoffrey K Broadhead, et al.
Ophthalmology. Retina|April 14, 2024
One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity: Data from the Fight Retinal Blindness! RegistryHemal Mehta, Pierre-Henry Gabrielle, Yohei Hashimoto, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Eye (London, England)|June 7, 2020
Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working GroupWinfried M Amoaku, Faruque Ghanchi, Clare Bailey, et al.
Eye (London, England)|July 24, 2020
Correction: Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working GroupWinfried M Amoaku, Faruque Ghanchi, Clare Bailey, et al.
Journal of Ophthalmology|February 24, 2023
Diabetic Macular Oedema Guidelines: An Australian PerspectiveYew Sen Yuen, Jagjit Singh Gilhotra, Michelle Dalton, et al.
Scientific Reports|June 22, 2026
A combined ex vivo fundus imaging-histology protocol for clinicopathological validation of human donor eyes with limited medical historySarrvesa H Vijay Singh, Waiwai Yeap, Lay Khoon Too, et al.
The British Journal of Ophthalmology|March 13, 2021
Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registryAdrian R Hunt, Vuong Nguyen, Catherine P Creuzot-Garcher, et al.
The British Journal of Ophthalmology|October 8, 2025
Minimum set of outcome measures for non-advanced age-related macular degeneration: a Delphi consensus statement by the TRACER (intermediate age-related macular degeneration) study groupMariano Cozzi, Sandrine Zweifel, Konstantinos Balaskas, et al.
BMJ Open|September 11, 2020
HEROIC: a 5-year observational cohort study aimed at identifying novel factors that drive diabetic kidney disease: rationale and study protocolKieran Mccafferty, Ben Caplin, Sinead Knight, et al.
Medrxiv : the Preprint Server for Health Sciences|August 29, 2022
Risk Factors Associated with Post-Acute Sequelae of SARS-CoV-2 in an EHR Cohort: A National COVID Cohort Collaborative (N3C) Analysis as part of the NIH RECOVER programElaine Hill, Hemal Mehta, Suchetha Sharma, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|March 5, 2026
Faricimab for previously-treated eyes with neovascular age-related macular degeneration with inadequate response - 6-month interim analysis of the FURGGHORN studyLong T Phan, Jennifer Chin, Geoffrey K Broadhead, et al.
Ophthalmology. Retina|April 14, 2024
One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity: Data from the Fight Retinal Blindness! RegistryHemal Mehta, Pierre-Henry Gabrielle, Yohei Hashimoto, et al.
Pageof 9